The pharma company has completed the purchase of worldwide exclusive Intellectual Property Rights for Fondaparinux sodium, its generic anti-coagulant drug, from Australian partner Alchemia for $17.5 million.
The scrip opened at Rs. 3386.05 and has touched a high and low of Rs. 3404.75 and Rs. 3140 respectively. So far 8,82,901 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 57583.01 crore.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 3010 on 09-Feb-2015. Last one week high and low of the scrip stood at Rs. 3518.35 and Rs. 3300 respectively.
The promoters holding in the company stood at 25.51 % while Institutions and Non-Institutions held 41.91 % and 14.35 % respectively.
The stock is currently trading above its 50 DMA.
No comments:
Post a Comment